Calcium antagonist treatment of recipients minimizes early cyclosporine nephrotoxicity in renal transplantation: a prospective randomized trial.
Morales
J M
JM
Nephrology Department, Hospital 1. de Octubre, Facultad de Medicina, Madrid, Spain.
Andrés
A
A
Prieto
C
C
Ortuño
B
B
Estenoz
J
J
Dorado
C
C
Arenas
J
J
Ruilope
L M
LM
Fernández-Cruz
L
L
Rodicio
J L
JL
D000328:Adult; D002986:Clinical Trials as Topic; D003524:Cyclosporins / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006085:Graft Survival; D006801:Humans; D007668:Kidney / Q000187:drug effects / Q000473:pathology; D016030:Kidney Transplantation; D007684:Kidney Tubules / Q000473:pathology; D008297:Male; D009336:Necrosis; D009543:Nifedipine / Q000627:therapeutic use*; D011446:Prospective Studies; D011897:Random Allocation
D003524:Cyclosporins; D009543:Nifedipine